Advertisement
Screener

BIOCERES CROP SOLUTIONS CORP. (BIOX) Repayments Of Borrowings Classified As Financing Activities

BIOCERES CROP SOLUTIONS CORP. Repayments Of Borrowings Classified As Financing Activities

BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Repayments Of Borrowings Classified As Financing Activities of $52.40 million for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-13.

Financial Statements › Cash Flow › Financing Activities

ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities · last filed 2026-03-13

  • BIOCERES CROP SOLUTIONS CORP. repayments of borrowings classified as financing activities for the quarter ending 2025-12-31 was $17.56M, a 26.21% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. repayments of borrowings classified as financing activities for the quarter ending 2025-09-30 was $34.84M, a 32.46% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. repayments of borrowings classified as financing activities for the quarter ending 2025-06-30 was $147.70M.
  • BIOCERES CROP SOLUTIONS CORP. repayments of borrowings classified as financing activities for the quarter ending 2025-03-31 was $65.37M, a 24.70% increase year-over-year.
Period endRepayments Of Borrowings Classified As Financing Activities 3 monthRepayments Of Borrowings Classified As Financing Activities 6 monthRepayments Of Borrowings Classified As Financing Activities 6 month as first filedRepayments Of Borrowings Classified As Financing Activities 9 monthRepayments Of Borrowings Classified As Financing Activities 9 month as first filedRepayments Of Borrowings Classified As Financing Activities 12 monthRepayments Of Borrowings Classified As Financing Activities 12 month as first filed
2025-12-31$17.56M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
$52.40M
6-K · filed 2026-03-13
$200.10M
derived: sum of 3 quarters · filed 2026-03-13
$265.47M
derived: sum of 4 quarters · filed 2026-03-13
2025-09-30$34.84M
6-K · filed 2025-11-26
$182.54M
derived: sum of 2 quarters · filed 2025-11-26
$247.91M
derived: sum of 3 quarters · filed 2025-11-26
$271.71M
derived: sum of 4 quarters · filed 2026-03-13
2025-06-30$147.70M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$213.07M
derived: sum of 2 quarters · filed 2025-11-10
$236.87M
derived: sum of 3 quarters · filed 2026-03-13
$288.45M
20-F · filed 2025-11-10
2025-03-31$65.37M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
$89.17M
derived: sum of 2 quarters · filed 2026-03-13
$140.75M
6-K · filed 2025-06-20
$121.70M
derived: sum of 4 quarters · filed 2026-03-13
2024-12-31$23.80M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
$75.38M
6-K · filed 2026-03-13
$78.07M
6-K · filed 2025-02-28
$56.33M
derived: sum of 3 quarters · filed 2026-03-13
$108.75M
derived: sum of 4 quarters · filed 2026-03-13
2024-09-30$51.59M
6-K · filed 2025-11-26
$32.53M
derived: sum of 2 quarters · filed 2025-11-26
$84.95M
derived: sum of 3 quarters · filed 2025-11-26
$117.33M
derived: sum of 4 quarters · filed 2025-11-26
2024-06-30-$19.06M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$33.36M
derived: sum of 2 quarters · filed 2025-11-10
$65.75M
derived: sum of 3 quarters · filed 2025-11-10
$112.61M
20-F · filed 2025-11-10
2024-03-31$52.42M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
$84.81M
derived: sum of 2 quarters · filed 2025-06-20
$131.67M
6-K · filed 2025-06-20
$20.56M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31$32.39M
derived: 6-K 6 month − 6-K 3 month · filed 2025-02-28
$79.25M
6-K · filed 2025-02-28
-$31.86M
derived: sum of 3 quarters · filed 2025-11-10
$17.02M
derived: sum of 4 quarters · filed 2025-11-10
2023-09-30$46.87M
6-K · filed 2024-11-27
-$64.24M
derived: sum of 2 quarters · filed 2025-11-10
-$15.36M
derived: sum of 3 quarters · filed 2025-11-10
$16.55M
derived: sum of 4 quarters · filed 2025-11-10
2023-06-30-$111.11M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$62.23M
derived: sum of 2 quarters · filed 2025-11-10
-$30.32M
derived: sum of 3 quarters · filed 2025-11-10
$16.74M
20-F · filed 2025-11-10
2023-03-31$48.88M
derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29
$80.79M
derived: sum of 2 quarters · filed 2024-05-29
$127.86M
6-K · filed 2024-05-29
$140.70M
6-K · filed 2023-05-24
$145.74M
derived: sum of 4 quarters · filed 2024-10-30
2022-12-31$31.91M
derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28
$78.97M
6-K · filed 2024-02-28
$88.65M
6-K · filed 2023-02-28
$96.86M
derived: sum of 3 quarters · filed 2024-10-30
$130.81M
derived: sum of 4 quarters · filed 2024-10-30
2022-09-30$47.06M
6-K · filed 2023-11-29
$64.95M
derived: sum of 2 quarters · filed 2024-10-30
$98.90M
derived: sum of 3 quarters · filed 2024-10-30
2022-06-30$17.89M
derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30
$51.84M
derived: sum of 2 quarters · filed 2024-10-30
$110.63M
20-F · filed 2024-10-30
$123.64M
20-F · filed 2022-10-28
2022-03-31$33.95M
derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24
$92.74M
6-K · filed 2023-05-24
2021-12-31$58.79M
6-K · filed 2023-02-28
2021-06-30$113.10M
20-F · filed 2023-11-14
$126.02M
20-F · filed 2021-10-29
2020-12-31$55.37M
6-K · filed 2022-02-25
2020-06-30$101.32M
20-F · filed 2022-10-28
2019-12-31$54.94M
6-K · filed 2021-02-26
2019-06-30$111.08M
20-F · filed 2021-10-29
2018-12-31$37.10M
6-K/A · filed 2020-03-17
2018-06-30$37.62M
20-F · filed 2020-10-21
2017-06-30$56.55M
20-F · filed 2019-10-24
2016-12-31$6.35M
20-F · filed 2019-10-24